您的购物车当前为空
别名 TCD-717
RSM-932A (TCD-717) 是一种特异性 ChoKα 抑制剂,对人重组 ChoKα 和 ChoKβ 酶的 IC50 分别为 1 和 33 μM。RSM-932A 具有有效的体内外抗肿瘤活性,并且毒性较低。


为众多的药物研发团队赋能,
让新药发现更简单!
RSM-932A (TCD-717) 是一种特异性 ChoKα 抑制剂,对人重组 ChoKα 和 ChoKβ 酶的 IC50 分别为 1 和 33 μM。RSM-932A 具有有效的体内外抗肿瘤活性,并且毒性较低。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 593 | 现货 | |
| 5 mg | ¥ 1,490 | 现货 | |
| 10 mg | ¥ 2,480 | 现货 | |
| 25 mg | ¥ 3,970 | 现货 | |
| 50 mg | ¥ 5,860 | 现货 | |
| 100 mg | ¥ 7,890 | 现货 | |
| 200 mg | ¥ 10,600 | 现货 |
| 产品描述 | RSM-932A (TCD-717) is a specific ChoKα inhibitor with IC50s of 1 and 33 μM against human recombinant ChoKα and ChoKβ enzymes, respectively. RSM-932A possesses potent ex vivo antitumor activity and low toxicity. |
| 体外活性 | RSM-932A exhibits effective anti proliferative activity against most tumor derived cell lines tested, including those from breast, lung, colon, bladder, liver, ovary, bone, cervix, kidney, pancreas, melanoma, and brain tumors, with an IC50 of 1.3-7.1 μM at 72 hours [1] |
| 体内活性 | RSM-932A exhibits strong in vivo anticancer activity and is not toxic at effective doses [1]. |
| 别名 | TCD-717 |
| 分子量 | 877.54 |
| 分子式 | C46H38Cl2N4Br2 |
| CAS No. | 850807-63-5 |
| Smiles | [Br-].[Br-].CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(cc2)-c2ccc(C[n+]3ccc(N(C)c4ccc(Cl)cc4)c4ccccc34)cc2)c2ccccc12 |
| 密度 | 1.31g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (62.68 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+90% Saline: 1.67 mg/mL (1.9 mM), Sonication is recommeded. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多